These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9174818)

  • 41. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
    Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
    Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male.
    Morales A; Lunenfeld B;
    Aging Male; 2002 Jun; 5(2):74-86. PubMed ID: 12198738
    [No Abstract]   [Full Text] [Related]  

  • 43. [Androgen deficiency in males and its correction in respect to pathogenesis of prostatic cancer].
    Mazo EB; Grigor'ev ME; Konorev VA; Ermisheva OM
    Urologiia; 2008; (3):57-8, 60-2. PubMed ID: 18669351
    [No Abstract]   [Full Text] [Related]  

  • 44. Testosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations.
    Morales A; Black AM; Emerson LE
    BJU Int; 2009 Jan; 103(1):62-4. PubMed ID: 18671790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Re: Ebert T, Jockenhövel F, Morales A, Shabsigh R. The current status of therapy for symptomatic late onset hypogonadism with transdermal testosterone gel. Eur Urol 2005;47:137-46.
    Ponholzer A; Rauchenwald M; Madersbacher S
    Eur Urol; 2005 Jul; 48(1):170-1; author reply 171. PubMed ID: 15967269
    [No Abstract]   [Full Text] [Related]  

  • 46. Pubertal androgen therapy in boys.
    Rogol AD
    Pediatr Endocrinol Rev; 2005 Mar; 2(3):383-90. PubMed ID: 16429115
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone metabolism and replacement therapy in patients with end-stage renal disease.
    Johansen KL
    Semin Dial; 2004; 17(3):202-8. PubMed ID: 15144546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypogonadism and erectile dysfunction: an overview.
    Gurbuz N; Mammadov E; Usta MF
    Asian J Androl; 2008 Jan; 10(1):36-43. PubMed ID: 18087642
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone.
    Hwang TI; Chen HE; Tsai TF; Lin YC
    Int J Impot Res; 2006; 18(4):400-4. PubMed ID: 16395321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Androgens and bone metabolism].
    Alexandre C; Rossi D; Tostain J
    Prog Urol; 2004 Nov; 14(5):719-29. PubMed ID: 15747620
    [No Abstract]   [Full Text] [Related]  

  • 53. Testosterone replacement therapy: current trends and future directions.
    Nieschlag E; Behre HM; Bouchard P; Corrales JJ; Jones TH; Stalla GK; Webb SM; Wu FC
    Hum Reprod Update; 2004; 10(5):409-19. PubMed ID: 15297434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Management of the cardinal features of andropause.
    Mooradian AD; Korenman SG
    Am J Ther; 2006; 13(2):145-60. PubMed ID: 16645432
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen therapy in women: what we think we know.
    Drillich A; Davis SR
    Exp Gerontol; 2007 Jun; 42(6):457-62. PubMed ID: 17407803
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between megestrol acetate treatment and symptomatic adrenal insufficiency with hypogonadism in male patients with cancer.
    Dev R; Del Fabbro E; Bruera E
    Cancer; 2007 Sep; 110(6):1173-7. PubMed ID: 17647248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgens: risks and benefits.
    Bardin CW; Swerdloff RS; Santen RJ
    J Clin Endocrinol Metab; 1991 Jul; 73(1):4-7. PubMed ID: 1710623
    [No Abstract]   [Full Text] [Related]  

  • 59. [Drug-induced improvement of sperm quality].
    Danner C
    Wien Med Wochenschr; 1982 Oct; 132(20):475-8. PubMed ID: 6925435
    [No Abstract]   [Full Text] [Related]  

  • 60. Micropenis: an animal model and its human correlates.
    Husmann DA
    Adv Exp Med Biol; 2002; 511():41-54; discussion 54-6. PubMed ID: 12575755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.